Weekly CEO & CFO Moves Update
This week saw notable executive leadership changes among U.S. public companies, particularly in the roles of CEO and CFO. Anterix Inc. announced the appointment of Scott Lang as CEO, succeeding Robert Harris Schwartz. Lang brings over 30 years of experience across telecommunications and utilities. Arts Way Manufacturing Co. also appointed Marc McConnell as CEO. McConnell previously served as the President of Bauer Corporation and has a background in diverse business operations.
Astec Industries and Benchmark Electronics made changes to their CFO positions. Brian Harris, formerly the EVP and CFO of Summit Materials, has joined Astec Industries as CFO, following Heinrich Jonker’s departure. At Benchmark Electronics, Bryan Schumaker has been appointed CFO, bringing extensive finance experience in technology and renewable energy sectors. Both transitions reflect ongoing adjustments to financial leadership across various industries.
Additional companies, including Black Diamond Therapeutics and Neurocrine Biosciences, made new appointments to their executive teams. Erika Jones joined Black Diamond Therapeutics as CFO, and Kyle Gano was appointed CEO of Neurocrine Biosciences. These leaders bring industry backgrounds that align with their respective companies’ focus areas in healthcare, technology, and finance. The series of appointments demonstrates a continuation of executive transitions as companies adapt to evolving business needs.
This Week’s CEO and CFO Moves
COMPANY | FLAGS | ROLE | LEAVING | JOINING | JOINER BIOGRAPHY |
---|---|---|---|---|---|
ANTERIX INC |
|
CEO | Robert Harris Schwartz 4.3 yrs -7.3% TSR |
Scott A Lang | Lang is a highly accomplished and seasoned global executive with a demonstrated history of innovation, having spent more than 30 years working with major companies at the intersection of telecommunications and electric utilities. As the former CEO and Executive Chairman for Silver Spring Networks, Inc., Lang played a major role in successfully positioning the company as an innovative leader within…read full bio |
ARTS WAY MANUFACTURING CO INC |
|
CEO | David Alan King 4.3 yrs -6.3% TSR |
Marc H McConnell | Mr. McConnell is currently the President of Bauer Corporation and McConnell Holdings, Inc. Mr. McConnell previously served as the Chairman of the Board, Chairman of the Audit Committee, Chairman of the Executive Committee of Integrated Financial Holdings, Inc., a financial holding company headquartered in Raleigh, North Carolina. Mr. McConnell had served as a director of Integrated Financial Holdi…read full bio |
ASTEC INDUSTRIES INC |
|
CFO | Heinrich Jonker .6 yrs *interim* -11.7% TSR |
Brian James Harris | Mr. Harris, age 68, served as Executive Vice President and Chief Financial Officer of Summit Materials, Inc. (“Summit”), a leading producer of aggregates and cement, from October 2013 to February 2023. Prior to his role at Summit, Mr. Harris served as Executive Vice President and Chief Financial Officer of Bausch + Lomb Corporation, an eye health products company, from 2009 to 2013. Prior to joini…read full bio |
BENCHMARK ELECTRONICS INC |
|
CFO | Arvind Kamal .5 yrs *interim* 46.0% TSR |
Bryan Robert Schumaker | Most recently Mr. Schumaker served as EVP and CFO of SOURCE Global, PBC, who produces the world’s first fully renewable drinking water system. Prior to that assignment Mr. Schumaker held CFO roles at TPI Composites, Inc. (NASDAQ:TPIC) and 8point3 Energy Partners (NASDAQ:CAFD), while previously serving as Senior Vice President and Chief Accounting Officer for First Solar, Inc. (NASDAQ:FSLR)….read full bio |
BLACK DIAMOND THERAPEUTICS INC |
|
CFO | Fang Ni 2.9 yrs *interim* -17.4% TSR |
Erika Jones | Erika Jones has served as our Senior Vice President, Finance since February 2024 and as Corporate Controller since January 2021. Ms. Jones previously served as Vice President, Finance from October 2021 until her promotion in February 2024. Ms. Jones joined the Company in 2019 and served as Senior Director, Finance from October 2019 to January 2021. Prior to joining us, from May 2016 to October 201…read full bio |
CERENCE INC |
|
CEO | Stefan Ortmanns 2.8 yrs -70.3% TSR |
Brian M Krzanich | Mr. Krzanich, 64, most recently served as Chief Executive Officer of CDK Global, an automotive software company, from 2018 to 2022. Prior to that, Mr. Krzanich served in a number of roles at Intel Corporation beginning in 1982, leading to his ascension to the role of Chief Executive Officer of Intel Corporation from 2013 to 2018. Under his leadership, Intel expanded from its core CPU mar…read full bio |
COHERENT CORP |
|
CFO | Richard Martucci 1.1 yrs *interim* |
Sherri R Luther | Ms. Luther, age 59, has served as the chief financial officer of Lattice Semiconductor Corporation (“Lattice”) since January 2019. Prior to joining Lattice, Ms. Luther was a senior financial executive at Coherent, Inc. for over sixteen years, and most recently served as its Corporate Vice President of Finance. Prior to joining Coherent, Inc., Ms. Luther held a number of…read full bio |
EASTSIDE DISTILLING INC |
|
CFO | Geoffrey C Gwin 4.3 yrs -60.8% TSR |
Christopher R Moe | Christopher R. Moe, Chief Financial Officer. Since 2023 Mr. Moe has served as the Chief Financial Officer of Beeline Financial Holdings, Inc. an AI assisted all digital home loan lending and title platform designed to simplify the process of home financing. From 2018 until 2023, he was the Chief Financial Officer and a Director of Yates Electrospace Corporation, a heavy payload contested…read full bio |
EMPLOYERS HOLDINGS INC |
|
CFO | Michael Scott Paquette 8.2 yrs 6.3% TSR |
Michael A. Pedraja | Mr. Pedraja, age 56, has served as Group Chief Financial Officer for Ariel Re Services, a global reinsurance underwriter and service provider, since May 2021. From April 2019 to April 2021, Mr. Pedraja served as Senior Vice President and Treasurer of The Allstate Corporation (NYSE:ALL). Prior to joining The Allstate Corporation, Mr. Pedraja worked as an investment banker for over 20 years focusing…read full bio |
GENESCO INC |
|
CFO | Thomas George 3.8 yrs 1.1% TSR |
Sandra Harris | Prior to joining the Company, Ms. Harris, age 52, served as Chief Financial Officer of Artisan Design Group, LLC from February 2023 to April 2024. Previously, Ms. Harris served as Tupperware Brands Corp.’s (“Tupperware”) (i) Chief Financial Officer and Chief Operating Officer from October 2020 to June 2022 and (ii) Executive Vice President and Chief Financial Officer from April 2…read full bio |
GOHEALTH INC |
|
CFO | Katherine O’Halloran .3 yrs |
Brendan Shanahan | Mr. Shanahan, age 62, has over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage industry. Prior to joining the Company as Chief Financial Officer, Mr. Shanahan served from March 2022 to February 2024 as Chief Financial Officer of UpStream Care Company, a primary care services and technology company, and from July 2015 to June 2021 as Executive Vi…read full bio |
INTREPID POTASH INC |
|
CEO | Robert P Jornayvaz III 10.1 yrs -16.6% TSR |
TBD | TBD |
LATTICE SEMICONDUCTOR CORP |
|
CFO | Sherri R Luther 5.8 yrs |
Tonya Steven | Ms. Stevens, age 52, joined the Company in May 2019 as its Vice President and Corporate Controller. While at Lattice, Ms. Stevens has led key strategic transformations that helped the company optimize its operations and strengthen its financial foundation. Prior to joining the Company, Ms. Stevens held finance leadership roles at a variety of companies, including Intel Corp. and Price Waterhouse C…read full bio |
NEUROCRINE BIOSCIENCES INC |
|
CEO | Kevin Charles Gorman 16.8 yrs 17.5% TSR |
Kyle Gano | Dr. Gano was appointed Neurocrine’s Chief Business Development Officer in 2011, and Chief Business Development and Strategy Officer in 2020, and is responsible for all of Neurocrine’s business and corporate development activities, including the management of ongoing collaborations with AbbVie, Mitsubishi Tanabe Pharma, Sentia Medical Sciences, Jnana Therapeutics, Voyager Therapeut…read full bio |
NRX PHARMACEUTICALS INC |
|
CEO | Stephen H Willard 2.3 yrs |
Jonathan C Javitt | Jonathan Javitt, M.D., M.P.H. Dr. Javitt, founder of the Company, serves as our Chairman and as Chief Scientist and was re-elected Chairman in December 2023. Dr. Javitt additionally served as the Company’s CEO from May 2021 until March 2022. He was the Co-founder, Chairman, and CEO of NeuroRx, Inc., which merged with the Company in May 2021. He participated in leading drug and medical device devel…read full bio |
NUVATION BIO INC |
|
CFO | Moses Makunje .9 yrs 121.0% TSR |
Philippe Sauvage | Prior to joining the Company, Mr. Sauvage, 47 years old, served as Senior Vice President, Global Head of Operations and Access for Sanofi from 2020 to 2024. Mr. Sauvage also served Sanofi as Head of Commercial Strategy and Portfolio Marketing – DUPIXENT from 2019-2020, Chief Financial Officer for Sanofi-Genzyme and Sanofi North America from 2015-2019, and Chief Financial…read full bio |
OPTINOSE INC |
|
CFO | Anthony J Krick 1.8 yrs *interim* -37.1% TSR |
Terry Kohler | Mr. Kohler, age 47, is an experienced biotech finance leader with over 20 years of business experience. He was most recently the Chief Financial Officer for Verrica Pharmaceuticals, a publicly-held dermatology therapeutics company, from July 2021 to October 2024, where he supported commercial preparations for the launch of a topical treatment for molluscum contagiosum and research and development…read full bio |
REALPHA TECH CORP |
|
CFO | William B Miller .2 yrs |
Rakesh Prasad | Mr. Prasad, age 35, has over 10 years of finance reporting and audit experience. Mr. Prasad has been with the Company since May 2021 as a Director of reAlpha Techcorp Private Limited, one of the Company’s subsidiaries, as a Finance Controller from such date until January 2022 and as the Vice President of Finance since February 2022, where he directs the preparation and consolidation of the C…read full bio |
TURNSTONE BIOLOGICS CORP |
|
CFO | Venkat Ramanan 2.7 yrs |
Wendy Worcester | From July 2018 to April 2020, from Ms. Worcester served as the Chief Financial Officer of Gateway Genomics, LLC, a biotechnology company developing fetal and infant DNA technology. Since 2007, Ms. Worcester has served as the Managing Director of WJW Consulting, a fractional and advisory chief financial officer services company. Ms. Worcester received a B.S. in Business with an…read full bio |
UNITED PARKS & RESORTS INC |
|
CFO | James (“Jim”) W. Forrester, Jr., 1.8 yrs *interim* -3.4% TSR |
James Mikolaichik | Prior to becoming the Company’s Chief Financial Officer, Mr. Mikolaichik, 53, served as the Chief Financial Officer of MyEyeDr., an eye health and wellness company, from December 2022 until October 2024. Prior to MyEyeDr., Mr. Mikolaichik served as the Chief Financial Officer of Diamond Resorts, a hospitality, vacation ownership and entertainment company, from September 2018 until August 202…read full bio |
UNIVERSAL TECHNICAL INSTITUTE INC |
|
CFO | Troy R Anderson 5.1 yrs 28.6% TSR |
Christine Kline (interim) |
Ms. Kline, age 46, has served as the Company’s Vice President and Chief Accounting Officer since December 2023. Prior to this role, she served as Vice President, Corporate Controller since joining the Company in February 2020. Prior to joining the Company, Ms. Kline served as the Director of Financial Reporting at Nuverra Environmental Solutions from July 2015 to February 2020 and…read full bio |
UROGEN PHARMA LTD |
|
CFO | Dong (Don) Kim 2.6 yrs 26.1% TSR |
Christopher William Degnan | Prior to joining the Company, Christopher Degnan, age 45, served as the Chief Financial Officer of Galera Therapeutics, Inc., a publicly traded biopharmaceutical company focused on oncology, from October 2019 to August 2024. Prior to Galera, Mr. Degnan served as the Chief Financial Officer of Verrica Pharmaceuticals Inc., a publicly traded biotechnology company focused on medical dermatology,…read full bio |
VIRPAX PHARMACEUTICALS INC |
|
CEO | Gerald W Bruce .9 yrs -91.2% TSR |
Jatinder Dhaliwal | Jatinder (Jay) Dhaliwal is a registered pharmacist and has served as CEO and director of multiple publicly traded companies listed in Canadian (CSE, TSX) and American (Nasdaq) exchanges. Since June 2022, Mr. Dhaliwal has served as director and chairman of the board of Akanda Corp., a leading seed to patient cannabis producer based out of Europe and currently listed on the Nasdaq. He also serv…read full bio |
VIRPAX PHARMACEUTICALS INC |
|
CFO | Vinay Shah 1.3 yrs -82.1% TSR |
TBD | TBD |
WORTHINGTON ENTERPRISES INC |
|
CEO | B Andrew Rose 4.1 yrs 14.9% TSR |
Joseph B Hayek | Mr. Hayek (age 52) currently serves as the Company’s Executive Vice President and Chief Financial and Operations Officer, and has served in such role since December 2023. Mr. Hayek previously served as the Company’s Vice President and Chief Financial Officer from November 2018 to November 2023. Mr. Hayek served as Vice President and General Manager of the Company’s oil and gas equipment business u…read full bio |
WORTHINGTON ENTERPRISES INC |
|
CFO | Joseph B Hayek 5.9 yrs 11.0% TSR |
Colin J. Souza | Mr. Souza (age 36) currently serves as the Company’s Vice President of Finance, and has served in such role since December 2023. Mr. Souza previously served as the Company’s Director of Corporate Development and Mergers & Acquisitions from January 2021 to December 2023, and as Manager of Corporate Development and Mergers & Acquisitions from July 2019 to December 2021. Prior to…read full bio |